Charlotte Dyring
Founder bij ExpreS2ion Biotechnologies ApS
Profiel
Charlotte Dyring is the founder of ExpreS2ion Biotechnologies ApS, which was founded in 2009.
She holds the title of Chief Operating Officer at the company.
She is also the founder of Expres2ion Biotech Holding AB, which was founded in 2010.
She held the title of Chief Operating Officer at the company from 2010 to 2020.
In addition to her founding positions, Dr. Dyring has former job experience.
She worked at Pharmexa A as a Principal, and she also worked at Kabi Pharmacia as a Principal.
Dr. Dyring's education history includes a doctorate degree from the Technical University of Denmark, which she received in 1992.
She also has an undergraduate degree from The Danish Academy of Technical Sciences.
Actieve functies van Charlotte Dyring
| Bedrijven | Functie | Begin |
|---|---|---|
ExpreS2ion Biotechnologies ApS
 ExpreS2ion Biotechnologies ApS BiotechnologyHealth Technology ExpreS2ion Biotechnologies ApS operates as a biotechnology company which engages in the field of protein production in Drosophila Schneider-2 cells. Its services include custom proteins and research & development reagents, process development, and feasibility studies. The company was founded by Charlotte Dyring, Martin Roland Jensen, and Willem Adriaan de Jongh in 2009 and is headquartered in Horsholm, Denmark. | Founder | 01-01-2009 |
Eerdere bekende functies van Charlotte Dyring
| Bedrijven | Functie | Einde |
|---|---|---|
| EXPRES2ION BIOTECH HOLDING AB | Founder | 01-12-2020 |
Pharmexa A/S
 Pharmexa A/S Pharmaceuticals: MajorHealth Technology Pharmexa A/S is a leading company in the field of active immunotherapy for the treatment of serious chronic diseases. Pharmexa's proprietary AutoVac(tm) technology platform is broadly applicable, but the company has focused its resources on a number of cancer forms and chronic inflammatory diseases, with research and development programs targeted towards breast cancer, rheumatoid arthritis and bone degeneration | Corporate Officer/Principal | - |
| Kabi Pharmacia | Corporate Officer/Principal | - |
Opleiding van Charlotte Dyring
| Technical University of Denmark | Doctorate Degree |
| The Danish Academy of Technical Sciences | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| EXPRES2ION BIOTECH HOLDING AB | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Pharmexa A/S
Pharmexa A/S Pharmaceuticals: MajorHealth Technology Pharmexa A/S is a leading company in the field of active immunotherapy for the treatment of serious chronic diseases. Pharmexa's proprietary AutoVac(tm) technology platform is broadly applicable, but the company has focused its resources on a number of cancer forms and chronic inflammatory diseases, with research and development programs targeted towards breast cancer, rheumatoid arthritis and bone degeneration | Health Technology |
| Kabi Pharmacia | |
ExpreS2ion Biotechnologies ApS
ExpreS2ion Biotechnologies ApS BiotechnologyHealth Technology ExpreS2ion Biotechnologies ApS operates as a biotechnology company which engages in the field of protein production in Drosophila Schneider-2 cells. Its services include custom proteins and research & development reagents, process development, and feasibility studies. The company was founded by Charlotte Dyring, Martin Roland Jensen, and Willem Adriaan de Jongh in 2009 and is headquartered in Horsholm, Denmark. | Health Technology |
